FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/07/034551 [Registered on: 02/07/2021] Trial Registered Prospectively
Last Modified On: 30/06/2021
Post Graduate Thesis  No 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Multiple Arm Trial 
Public Title of Study   To compare three maintenance doses of Dexmedetomidine for intravenous sedation in third molar extraction surgery 
Scientific Title of Study   A comparative clinical trial comparing three maintenance doses of Dexmedetomidine for intravenous sedation in third molar extraction surgery 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Hemant Batra 
Designation  Principal cum Professor and Head of Department, Oral and maxillofacial Surgery 
Affiliation  Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital 
Address  Dr. Hemant Batra, Principal cum Professor , head of department , Department of oral and Maxillofacial surgery , Dr. harvansh Singh Judge Institute of Dental sciences, Panjab University , Chandigarh

Chandigarh
CHANDIGARH
160014
India 
Phone  9814555550  
Fax    
Email  hemant_batra69@yahoo.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Hemant Batra 
Designation  Principal cum Professor and Head of Department, Oral and maxillofacial Surgery 
Affiliation  Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital 
Address  Dr. Hemant Batra, Principal cum Professor , head of department , Department of oral and Maxillofacial surgery , Dr. harvansh Singh Judge Institute of Dental sciences, Panjab University , Chandigarh

Chandigarh
CHANDIGARH
160014
India 
Phone  9814555550  
Fax    
Email  hemant_batra69@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Hemant Batra 
Designation  Principal cum Professor and Head of Department, Oral and maxillofacial Surgery 
Affiliation  Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital 
Address  Dr. Hemant Batra, Principal cum Professor , head of department , Department of oral and Maxillofacial surgery , Dr. harvansh Singh Judge Institute of Dental sciences, Panjab University , Chandigarh

Chandigarh
CHANDIGARH
160014
India 
Phone  9814555550  
Fax    
Email  hemant_batra69@yahoo.com  
 
Source of Monetary or Material Support  
Dept of Oral and Maxillofacial Surgery Dr Harvansh Singh Judge Institute of Dental Sciences and Hospital, PU 
 
Primary Sponsor  
Name  Dr Harsimran Kaur 
Address  Room no 5 Dept of Oral and Maxillofacial Surgery Dr. Harvansh Singh Judge Institute of dental sciences and hospital, Sector 25 , Panjab University , Chandigarh 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
Dr Bhavya Mishra  Room no 5 Dept of Oral and Maxillofacial Surgery Dr. Harvansh Singh Judge Institute of dental sciences and hospital, Sector 25 , Panjab University , Chandigarh 
Dr Hemant Batra  Room no 5 Dept of Oral and Maxillofacial Surgery Dr. Harvansh Singh Judge Institute of dental sciences and hospital, Sector 25 , Panjab University , Chandigarh 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Harsimran Kaur  Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital  Department of Oral and Maxillofacial Surgery, Dr. Harvansh Singh Judge Institute of Dental Sciences and Hospital,Sector 25 , Panjab University
Chandigarh
CHANDIGARH 
9888240333

sim820@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Research Degree Committee, Dr Harvansh Singh Judge Institute of Dental Sciences and Hospital, Panjab University, Chandigarh  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: K011||Impacted teeth,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Dexmedetomidine  Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.2 mcg/ Kg/ hr  
Intervention  Dexmedetomidine  Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.2 mcg/ Kg/ hr  
Comparator Agent  Dexmedetomidine  Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.4 mcg/ Kg/ hr  
Intervention  Dexmedetomidine   Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.4 mcg/ Kg/ hr  
Comparator Agent  Dexmedetomidine  Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.6 mcg/ Kg/ hr  
Comparator Agent  Dexmedetomidine   Loading dose 1mcg/kg over 10 minutes and maintenence dose of 0.6 mcg/ Kg/ hr  
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  60.00 Year(s)
Gender  Both 
Details  ASA 1 patient
Patient requiring 3rd molar extraction surgery under LA
Patient willing for intravenous sedation during the procedure
 
 
ExclusionCriteria 
Details  Pregnant females
Lactating mothers.
Patient with history of drug allergy to any drug.
Patient on any medication
History of dental treatment phobia
Abnormal gag reflex
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Centralized 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Primary objectives: to compare the following parameters:
1. Sedation scores
2. Pain scores
3. Hemodynamic and respiratory effects
4. Time of discharge of patient

Secondary objectives: to compare the following parameters:

1. Amnesia
2. Surgeon satisfaction score
3. Patient satisfaction score
4. Duration of analgesia
5. Requirement of rescue sedation
6. Any other side effects noted during the procedure
 
Parameters like heart rate , Systolic and diastolic BP, Respiratory rate ,SPO2 and ECG shall be noted pre operatively and then every 5 minutes till Till PARSAP score of greater than equal to 18 is achieved.
VAS score is calculated from starting the drug infusion till the end of the procedure for every 5 minutes.
PARSAP score is calculated after the procedure is complete till it is greater than equal to 18 for every 10 minutes. 
 
Secondary Outcome  
Outcome  TimePoints 
1. Amnesia
2. Surgeon satisfaction score
3. Patient satisfaction score
4. Duration of analgesia
5. Requirement of rescue sedation
6. Any other side effects noted during the procedure 
1. Amnesia- The patient will be asked to recall a pin prick given after 20 minutes of procedure post operatively
2. Surgeon satisfaction score: noted post operatively
3. Patient satisfaction score: noted post operatively
4. Duration of Analgesia- noted postoperatively
5. Requirement of rescue sedation with 1 mg intravenous Midazolam if Ramsay sedation score is 1 during the procedure
6. Any other side effects in the intraoperative or postoperative period will be noted 
 
Target Sample Size   Total Sample Size="87"
Sample Size from India="87" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   05/07/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - YES
  1. What data in particular will be shared?
    Response - All of the individual participant data collected during the trial, after de-identification.

  2. What additional supporting information will be shared?
    Response -  Study Protocol
    Response -  Statistical Analysis Plan
    Response - Informed Consent Form
    Response - Clinical Study Report
    Response -  Analytic Code

  3. Who will be able to view these files?
    Response - Anyone

  4. For what types of analyses will this data be available?
    Response - Any purpose.

  5. By what mechanism will data be made available?
    Response (Others) -  The scientific journal in which the study will be published in future.

  6. For how long will this data be available start date provided 05-07-2022 and end date provided 05-07-2027?
    Response - Immediately following publication. No end date.

  7. Any URL or additional information regarding plan/policy for sharing IPD? 
    Additional Information - NIL
Brief Summary  

In the present study we aim to evaluate and compare different parameters in three groups of patients receiving different maintenance doses of dexmedetomidine during third molar extraction surgery and to determine the ideal maintenance dose of Dex suitable for sedation with minimal side effects and early discharge from the OPD of the Department of Oral and Maxillofacial Surgery , Dr. HSJ Institute of Dental Sciences, Chandigarh.

The  three maintenance doses of Dexmedetomidine (0.2, 0.4 and 0.6 mcg/kg/hr) shall be compared for their hemodynamic and respiratory effects; onset and time of sedation (achieving a Ramsay score of ≥2 and Ramsay score of ≤2 after the procedure, respectively); Ramsay sedation scores during the procedure; recovery and discharge time.

 
Close